Skip to Content

Join the 'Colorectal Cancer' group to help and get support from people like you.

Colorectal Cancer News

Related terms: Anal Cancer, Cancer, Anal, Cancer, Colon, Cancer, Colorectal, Cancer, Rectal, Colon Cancer, Colon Carcinoma, Colorectal Carcinoma, Rectal Cancer

Lack of Exercise Can Boost Cancer Risk

Posted 2 days ago by Drugs.com

MONDAY, Aug. 13, 2018 – Few Americans know that inactivity can increase the risk of colon, breast and other types of cancer, a new study finds. An analysis of survey responses from 351 people revealed that while many knew a sedentary lifestyle increased their risk of heart disease (63.5 percent) and metabolic problems such as diabetes (65.8 percent), only 3.4 percent were aware it also adds to ...

To Boost Colon Cancer Screening, Use the Mail

Posted 15 days ago by Drugs.com

TUESDAY, July 31, 2018 – Colon cancer is treatable if caught early. And sending screening tests in the mail might boost timely detection, a new study suggests. University of North Carolina (UNC) researchers found that Medicaid patients were more likely to get screened if they received stool-testing kits by mail instead of just reminders. "There has been a national push to increase colorectal ...

3-Pronged Approach to Cancer Prevention

Posted 26 Jul 2018 by Drugs.com

THURSDAY, July 26, 2018 – Need another reason to improve your diet and start exercising? Doing so could help ward off cancer, a new study finds. "Keep in mind that every lifestyle factor counts and it is never too late to adopt a healthy lifestyle," said study co-author Bernard Srour, of the French National Institute of Health and Medical Research. Eating healthful foods, engaging in physical ...

Too Few Americans Getting Screened for Cancer: CDC

Posted 26 Jul 2018 by Drugs.com

THURSDAY, July 26, 2018 – Routine checks for breast, prostate, cervical and colon cancer save lives, but screening rates for all but colon cancer have stalled in recent years, U.S. health officials report. According to the new U.S. Centers for Disease Control and Prevention study, the number of Americans getting recommended cancer screening remains below target levels. This is especially the ...

Could Diet Soda Help Curb Colon Cancer's Return?

Posted 20 Jul 2018 by Drugs.com

FRIDAY, July 20, 2018 – A new study suggests that colon cancer patients who regularly drink diet sodas have a much lower risk of their tumor coming back, or of dying from the cancer. In a study funded by the U.S. National Cancer Institute, researchers tracked outcomes for more than 1,000 colon cancer patients. The investigators found that those who drank one or more 12-ounce servings of ...

Health Tip: If You're 45 or Older, Get Screened for Colorectal Cancer

Posted 12 Jul 2018 by Drugs.com

-- The American Cancer Society's new colorectal cancer screening guidelines recommend that people at average risk start screening at age 45. That's a drop of five years from the former guidelines, which recommended the first screening at age 50. In lowering the age recommendation, the society cited rising numbers of colorectal cancer cases among younger Americans. Screening should begin even ...

Opdivo (nivolumab) + Low-Dose Yervoy (ipilimumab) Combination Approved for Previously Treated MSI-H/dMMR Metastatic Colorectal Cancer

Posted 12 Jul 2018 by Drugs.com

PRINCETON, N.J.-- July 11, 2018 (BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE: BMY) today announced Opdivo (nivolumab) 3 mg/kg plus low-dose Yervoy (ipilimumab) 1 mg/kg (injections for intravenous use) received approval from the U.S. Food and Drug Administration (FDA) for the treatment of adult and pediatric patients 12 years and older with microsatellite instability high (MSI-H) or ...

End-of-Life Care Depends on Doctor

Posted 10 Jul 2018 by Drugs.com

MONDAY, July 9, 2018 – The amount spent on end-of-life care for cancer patients varies widely across the United States, and is largely influenced by doctor preferences, new research finds. "Numerous studies have shown that greater spending and more care at the end of life do not contribute to better outcomes," said study author Nancy Keating. She's a professor of health care policy and medicine ...

Vitamin D May Guard Against Colon Cancer

Posted 15 Jun 2018 by Drugs.com

FRIDAY, June 15, 2018 – The sun you get when you mow the lawn or run errands could protect you against colon cancer, new research shows. How? Sunlight prompts the production of vitamin D, and people with sufficient levels of the vitamin had a 22 percent lower risk of colon cancer, said lead researcher Marjorie McCullough. She's senior scientific director of epidemiology research for the American ...

Balanced Diet May Be Key to Cancer Survival

Posted 13 Jun 2018 by Drugs.com

TUESDAY, June 12, 2018 – Eating a nutritionally balanced high-quality diet may lower a cancer patient's risk of dying by as much as 65 percent, new research suggests. The finding that total diet, rather than specific nutritional components, can affect a cancer patient's prognosis "was particularly surprising to us," said the study's lead author, Ashish Deshmukh. Total diet, he explained, was one ...

Cancer Care Twice as Costly in U.S. Versus Canada

Posted 1 Jun 2018 by Drugs.com

FRIDAY, June 1, 2018 – What a difference a border makes, when it comes to the cost of cancer care. Common chemotherapy for advanced colorectal cancer costs twice as much in Washington state as it does a short walk across the Canadian border into British Columbia, researchers report. A month's worth of chemotherapy cost $12,345 on the U.S. side of the border versus $6,195 just over the line into ...

ACS Updates Colorectal Cancer Screening to Start at Age 45

Posted 31 May 2018 by Drugs.com

WEDNESDAY, May 30, 2018 – Colorectal cancer (CRC) screening should begin at age 45 for people at average risk, according to updated guidelines from the American Cancer Society published online May 30 in CA: A Cancer Journal for Clinicians. Andrew M.D. Wolf, M.D., from the University of Virginia School of Medicine in Charlottesville, and colleagues conducted a systematic evidence review of the ...

Triclosan, A Widely Used Antibacterial Tied to Colon Woes in Mice

Posted 30 May 2018 by Drugs.com

WEDNESDAY, May 30, 2018 – Exposure to triclosan – a chemical in some shampoos and toothpastes – might raise the risk for colon inflammation and colon cancer, at least in mice, researchers say. New study results "suggest that triclosan could have adverse effects on gut health," said study leader Guodong Zhang, a food scientist at the University of Massachusetts Amherst. Triclosan is a common ...

New Guidelines Lower Colon Cancer Screening Age to 45

Posted 30 May 2018 by Drugs.com

WEDNESDAY, May 30, 2018 – Most people should now begin colorectal cancer screening at age 45, say new guidelines that were spurred by the rising rate of the disease among younger Americans. For years, the American Cancer Society (ACS) and other medical groups have advised people at average risk of colon and rectal cancer to begin screening at age 50. Earlier screening has been reserved for ...

Blue's Clues: Adding Dye to Colonoscopy May Boost Detection

Posted 22 May 2018 by Drugs.com

TUESDAY, May 22, 2018 – By having patients swallow a blue dye tablet as part of colonoscopy prep, doctors can boost their chances of catching telltale signs of cancer, new research suggests. The dye is technically referred to as "oral delayed-release methylene blue." When patients ingested the dye in tablet form alongside their usual pre-procedure cleansing preparation, it worked to highlight ...

Page 1 2 3 ... Next

Ask a Question

Further Information

Related Condition Support Groups

Familial Adenomatous Polyposis, Cancer

Related Drug Support Groups

methotrexate, fluorouracil, Avastin, Xeloda, Keytruda, Opdivo, Erbitux, capecitabine, nivolumab, view more... oxaliplatin, Stivarga, Yervoy, Cyramza, Betaseron, leucovorin, Lonsurf, pembrolizumab, Vectibix, Eloxatin, bevacizumab, ramucirumab, cetuximab, Mvasi, irinotecan, interferon beta-1b, levamisole, panitumumab, Zaltrap, levoleucovorin calcium, tipiracil / trifluridine, Wellcovorin, Ergamisol, ipilimumab, ziv-aflibercept, Camptosar, regorafenib, Adrucil, Fusilev